Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 vistas
• 07/14/23
0
0
Empotrar
administrator
Suscriptores
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios